Ethical Considerations for the Inclusion of Patient-Reported Outcomes in Clinical Research

These international, consensus-based, patient-reported outcomes (PRO)–specific guidelines aim to lay out the ethical considerations that researchers, research e

Related Keywords

Helsinki ,Eteläuomen Läi ,Finland ,Japan ,Tokyo ,Facit ,Lancashire ,United Kingdom ,Nuffield ,Oxfordshire ,Edgbaston ,Birmingham ,Canada ,West Midlands ,United Kingdom General ,Canadian ,Amanda Hunn ,Daiichi Sankyo ,Haf Davies ,Melaniej Calvert ,Cruz Rivera ,Glaxosmithkline ,Research Council Experimental Medicine ,Nipro Corp ,Japan Media Corp ,Language Summaries For The Research Participants ,Astrazeneca ,International Delphi ,Birmingham Health Partners Centre For Regulatory Science ,Birmingham Biomedical Research Centre ,National Institutes Of Health ,Clinical Academic Program Doctoral Research Fellowship ,Medrio Inc ,Welby Inc ,Urogen Pharma Ltd ,Regulatory Agency ,International Society For Quality Of Life Research ,Department Of Clinical Trial Data Management ,Gilead Sciences Ltd ,Microbiology Research Centre ,Institute Of Applied Health Research ,Association Of Community Cancer Centers ,Linkedin ,Veloxis Pharmaceuticals ,Research Collaboration West Midlands ,Health Foundation ,Transparency Of Health Research ,Mode Of Administration ,Takeda Pharmaceutical Co ,University Of Birmingham Ethical Review Board ,Aparito Ltd ,Health Research Authority ,Aetion Inc ,European Medicines Agency ,Health Education England ,Care Research ,Canadian Interagency Panel On Research Ethics ,Pfizer Japan Inc ,Amgen ,Vaccines Expert Advisory Group ,National Cancer Institute ,Members Of The Public Been Incorporated ,Pfizer ,International Consensus Meeting ,Input Has Not Been Sought Or Incorporated ,Ethics Operations Group ,Department Of Health ,Deceased Donor Family Tissue Advisory Group ,Japan Tobacco Inc ,Research Foundation ,Ethics Steering Group ,Faron Pharmaceuticals ,European Regional Development Fund ,Canadian Institutes Of Healthcare Research ,United Kingdom Research ,Health Literature ,Drug Administration ,Henry Ford Cancer Center ,National Institute For Health ,Centre For Patient Reported Outcome Research ,Core Outcome Measures In Effectiveness Trials Initiative ,Medidata Solutions ,Defence Medical Services ,Health Data Research United Kingdom ,School Of Medicine ,Genentech ,Regulatory Agency Clinical Trials ,Twitter ,Cancer Research United Kingdom Clinical Committee ,Purchaser Business Group On Health ,University Of Birmingham ,Foundation Fellowship ,Nuffield Bioethics Working Group ,Council Policy Statement ,Bristol Myers Squibb ,University Hospitals Birmingham ,Overall Health ,Ethical Conduct For Research Involving Humans ,Peterg Peterson Foundation ,University Of Warwick ,University Of Tokyo ,Outcomes Research Institute ,Johnson ,Council For International Organizations Of Medical Sciences ,Health Research ,Standard Protocol Items ,Interventional Trials ,Steering Group ,Birmingham Ethical Review Board ,Candidate Items ,Complementary Medicine Database ,Cumulative Index ,Allied Health Literature ,Delphi Process ,Operations Group ,Core Outcome Measures ,Effectiveness Trials ,Consensus Meeting ,Voting Process ,Specific Research ,How Clearly Are ,Are Any ,Specific Eligibility Requirements Identified ,Literacy Requirements ,How Clearly Have These Been ,Overall Health Related Quality ,Specific Domain ,Specific Symptom ,Instruments Have Been ,How Has ,Change From Baseline ,Final Value ,Principal Time Point ,Been Specified ,How Well Does ,Participant Information Sheet Provide ,Primary End Point ,What Justification Is Provided ,Data Collection ,What Details About ,Data Collection Plan Have Been Provided ,Permitted Mode ,Concerning Responses Will Occur During ,How Will This Inform ,Clinical Care ,Individual Study ,How Have Barriers ,Cultural Needs ,Been Minimized ,Promote Participant ,How Has Participant Acceptability ,Burden Been Described ,Contexts Where Participants Are Not Able ,May Become Unable ,How Will ,Proxy Reporting ,How Has Input From Patient Partners ,Public Been Incorporated ,Input Has Not Been Sought ,How Has This Been ,Symptom Burden Questionnaire ,What Mechanisms Have Been Introduced ,Minimize Missing ,How Have These Been Explained ,Follow Up Calls ,What Dissemination Plans ,Plain Language Summaries ,Research Participants ,Care Proposed ,Belmont Report ,International Organizations ,Medical Sciences ,Tri Council Policy Statement ,Ethical Conduct ,Research Involving ,Box Section Ref ,Patient Reported Outcome Research ,Applied Health Research ,Drs Cruz Rivera ,Interest Disclosures ,Demand Hub ,National Institute ,Birmingham Women ,Transplant Deceased Donor Family Tissue Advisory ,Drs Ells ,Canadian Interagency Panel ,Research Ethics ,Canadian Tri Council Policy Statement ,Health Education ,Clinical Trial Data Management ,Graduate School ,New Age Trading ,Ono Pharmaceutical ,Medi Solution ,Ayumi Pharmaceutical ,National Institutes ,Northwestern University George ,Brien Kidney Core ,International Society ,Life Research ,Clovis Oncology ,Select Foundation Fellowship ,Royal Hobart Hospital ,Navigating Cancer ,Community Cancer Centers ,Purchaser Business Group ,Sivan Innovation ,Urogen Pharma ,Clinical Trials ,Medical Research Council Experimental Medicine ,Cancer Research United Kingdom Clinical ,Birmingham Health Partners Centre ,Regulatory Science ,Biomedical Research Centre ,Innovate United Kingdom ,Macmillan Cancer Support ,Patient Centered Outcomes Research Institute ,European Regional Development ,Canadian Institutes ,Healthcare Research ,Social Care ,Executive Deputy Editor ,Janssen Global Services ,